Dosage GuidelinesAs directed by physician
Last month, CVS Caremark announced that it had struck a deal to make Novo's Wegovy its primary weight loss drug starting in the second half of the year, which would mean coverage for Lilly's Zepbound would no longer be preferred
But it would allow physicians to prescribe them both for the conditions discussed during the meeting, such as ulcerative colitis in the case of BPC-157, but also other uses when medically appropriate, such as athletic or cognitive performance
These changes make weight gain almost inevitable, even for women who maintain healthy habits
Diehl AM (2004) Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease
Your provider may also review your medication regimen to identify potential drug interactions or consider adjusting the tirzepatide dose if side effects are limiting tolerability